Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07013747RecruitingPhase 1/Phase 2
Acne mRNA vaccine for mild acne
This trial tests an mRNA vaccine designed to treat mild facial acne. It aims to see if the vaccine is safe and effective at reducing acne lesions.
Encino, CaliforniaAges 18–45 - NCT07015905RecruitingPhase 3
Study of REGN7508 vs. standard blood thinners after knee replacement
This trial compares a new blood thinner called REGN7508 to two standard blood thinners (apixaban and enoxaparin) to prevent blood clots after total knee replacement surgery. The goal is to see which is safer and more effective.
Sheffield, AlabamaAges 18 years+ - NCT06988215Recruiting
Taping and swallowing exercises for stroke patients with swallowing difficulty
This trial tests whether kinesiology taping (a special tape placed on the skin) combined with swallowing exercises can help people who have had a stroke and have trouble swallowing. It may improve muscle thickness and swallowing function.
Istanbul, bahçelievlerAges 50–80 - NCT07017023RecruitingEarly Phase 1
Blood pressure meds and activity scheduling for low mood
This study tests if taking a blood pressure medication (losartan) combined with a simple scheduling of pleasant activities can help improve low mood. It aims to see if these treatments work better together.
Oxford, OxfordshireAges 18–65 - NCT07015762RecruitingPhase 1
Testing IBI3002 for moderate-to-severe eczema
This trial tests a new drug called IBI3002 in people with moderate-to-severe atopic dermatitis (eczema) to see if it is safe and tolerable. It may help reduce skin inflammation and itching.
Suzhou, JiangsuAges 18–65 - NCT07015749RecruitingPhase 1
IBI3002 for moderate to severe asthma
This trial tests a new drug called IBI3002 for people with moderate to severe asthma that isn't well controlled with standard inhalers. It aims to see if the drug is safe and tolerable when given multiple times.
Suzhou, JiangsuAges 18–65 - NCT07016321RecruitingPhase 2/Phase 3
Emetine for Dengue: A Hospital Trial
This trial tests whether a medicine called emetine can help adults hospitalized with dengue. If you have a confirmed dengue infection and symptoms like fever, headache, or body aches, this study may be for you.
Baltimore, MarylandAges 18–65 - NCT07022366Recruiting
Brain effects of a serotonin blocker in healthy adults
This study tests how a drug that blocks a serotonin receptor affects thinking, memory, and mood. It helps researchers understand the role of serotonin in the brain.
OxfordAges 18–45 - NCT07023679Recruiting
Stellate ganglion shot with morphine for heart attack patients
This study tests if a painkiller (morphine) injected near certain neck nerves can reduce damage to the heart muscle during a heart attack procedure. It is for people having a specific type of heart attack and who will get a stent to open the blocked artery.
HefeiAges 18 years+ - NCT07018557RecruitingPhase 4
Eszopiclone for sleep and blood pressure in insomnia with high blood pressure
This trial tests if a sleep medication (eszopiclone) can lower blood pressure in people who have both insomnia and high blood pressure. You may qualify if you have trouble sleeping and your blood pressure is not well controlled despite treatment.
São Paulo, São PauloAges 30–75 - NCT07015528Enrolling by invitationEarly Phase 1
Drug liking study for surgery patients
This study looks at how much patients like the feeling of a drug given during a procedure. It may help doctors understand which medicines work best for comfort during surgery.
Palo Alto, CaliforniaAges 18 years+ - NCT07021859Recruiting
Migraine with aura study using CGRP to trigger attacks
This study tests whether a substance called CGRP (a protein linked to migraines) can safely trigger a migraine with aura in people who already have this condition. You'll receive an infusion and be monitored to see how your body responds.
Glostrup MunicipalityAges 18–65 - NCT07021794RecruitingPhase 2
Antibody treatment for Long COVID symptoms
This study tests whether a lab-made antibody (sipavibart) can reduce Long COVID symptoms. It is for people who developed Long COVID after a confirmed COVID infection and still have moderate to severe fatigue and other ME/CFS-like symptoms.
Fort Lauderdale, FloridaAges 18–70 - NCT07016074RecruitingPhase 2
Nitrate to prevent kidney injury from contrast dye
This trial tests whether a simple inorganic nitrate pill can protect your kidneys from damage caused by contrast dye used in heart catheterization or CT scans. It is for people whose kidneys are already somewhat weak, making them at higher risk for this type of injury.
Ann Arbor, MichiganAges 18 years+ - NCT07018622RecruitingPhase 2
Protecting kidneys from platinum chemotherapy damage
This trial tests a way to protect your kidneys while you receive platinum-based chemotherapy (cisplatin or carboplatin) for a solid tumor. It may help reduce the risk of kidney damage so you can complete your treatment more safely.
México, TlalpanAges 18 years+ - NCT06996704RecruitingPhase 1
Study of AK0610 in healthy adults
This trial tests a new drug called AK0610 in healthy volunteers aged 18 to 50. It helps researchers understand how the drug works in the body and whether it is safe before moving to larger studies.
Jinan, ShandongAges 18–50 - NCT05324475Recruiting
Nutritional supplement to support immunity and energy in older adults
This trial tests whether a safe nutrition supplement can help older adults with malnutrition maintain immune function and energy (mitochondrial function). It may support recovery during rehabilitation, but you must meet specific nutrition and health criteria.
Lausanne, SwitzerlandAges 75 years+ - NCT07005180RecruitingPhase 2
Carbon monoxide gas for Parkinson's disease
This trial tests if a low dose of carbon monoxide (HBI-002) is safe and helpful for people with Parkinson's disease. It requires specific health criteria and stable Parkinson's medication.
Fountain Valley, CaliforniaAges 40–80 - NCT07011524RecruitingPhase 2
Study of CM512 injection for moderate-to-severe asthma
This trial tests a new injection, CM512, for people with moderate-to-severe asthma that is not well controlled with current inhalers. It aims to see if the treatment can reduce asthma attacks and improve symptom control.
Guangzhou, GuangdongAges 18–75 - NCT07011732RecruitingPhase 3
Testing a drug for Alzheimer's-related agitation
This study tests an experimental drug (KarXT) to see if it safely reduces agitation in people with Alzheimer's disease. It may help if you or your loved one experiences restlessness, aggression, or irritability related to Alzheimer's.
Scottsdale, ArizonaAges 55–90 - NCT07012395RecruitingPhase 2
Long-acting antibodies for moderate to severe ulcerative colitis
This study tests new long-acting antibodies, given alone or in combination, for people with moderate to severe ulcerative colitis. The goal is to see if these treatments can help reduce inflammation and improve symptoms.
Canoga Park, CaliforniaAges 18–75 - NCT07009171RecruitingPhase 2
Testing KDS2010 for weight loss in overweight or obese adults
This study tests a new medication called KDS2010 for people who are overweight or have obesity. The goal is to see if it helps with weight loss when combined with diet and exercise.
Suwon, Gyeonggi-doAges 18 years+ - NCT07008456RecruitingPhase 2
Testing a new sugar-bead treatment for weight loss in obesity
This study tests a new treatment—small beads of sugar that release in the lower intestine—to help people with obesity and related health conditions lose weight. It compares two different doses of the beads plus a gel to a placebo (inactive treatment).
Tbilisi, K'alak'i T'bilisiAges 18–75 - NCT07005713RecruitingPhase 1
Study of tacabrutideg for chronic spontaneous urticaria
This trial tests a new oral medication called tacabrutideg (BGB-16673) for chronic spontaneous urticaria, a condition with frequent hives and itching. It aims to see how safe it is and how well it works, possibly offering a new option for people who still have symptoms despite antihistamines.
Beijing, Beijing MunicipalityAges 18–70
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,158 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.